Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Clinical Stage III Gastric Cancer AJCC v8 × Endoscopy × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 2 Adenocarcinoma Of Esophagus 2 Rectal Neoplasms 1 Ovarian Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1

Interventions

berzosertib 1 Magnetic Resonance Spectroscopy 1 Irinotecan 1 Endoscopy 1 Endoscopic Mucosal Resection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03641313 2026-04-13

Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting

17 enrolled 14 charts

Gastrointestinal

Clinical Stage III Gastric Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon ⚡